Search Within

Marcel R M Van Den Brink

Formats
  1. Meeting Abstract (341)
  2. Journal Article (247)
  3. Review (12)
  4. Research Letter (5)
  5. Correspondence (4)
  6. Editorial (3)
  7. Book Section (2)
  8. Conference Paper (1)
  9. Miscellaneous (1)
Groups
  1. Center for Hematologic Malignancies (616)
  2. Department of Medicine (616)
  3. Executive Committee, Center for Hematologic Malignancies (616)
  4. GSK Faculty (616)
  5. Hematologic Malignancies, Division of (616)
  6. Immunology Program Faculty (616)

More Groups

People
  1. Miguel-Angel Perales (174)
  2. Sergio Giralt (131)
  3. Jonathan Peled (121)
  4. Odette Smith (95)
  5. Robert Jenq (94)
  6. Doris Ponce (90)

More People

Years
  1. 2025 (1)
  2. 2024 (15)
  3. 2023 (36)
  4. 2022 (29)
  5. 2021 (25)
  6. 2020 (29)

More Years

Publications
  1. Blood (211)
  2. Biology of Blood and Marrow Transplantation (127)
  3. Bone Marrow Transplantation (29)
  4. Journal of Immunology (18)
  5. Journal of Clinical Oncology (12)
  6. Journal of Clinical Investigation (9)

More Publications

Publishers
  1. American Society of Hematology (218)
  2. Elsevier Inc. (150)
  3. Nature Publishing Group (73)
  4. The American Association of Immunologists, Inc (18)
  5. Cell Press (16)
  6. American Association for Cancer Research (12)

More Publishers

Results (616)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The role of the Fas ligand and perforin cytotoxic pathways in graft-versus-host-disease, graft-versus-leukemia and donor leukocyte infusion
    Meeting Abstract

    Kappel, B. J.; Muriglan, S. J.; Rotolo, J.; Horndasch, K. J.; Teshima, T.; Ferrara, J. L.; Burakoff, S. J.; van den Brink, M. R. M.
    Acta Haematologica (2000)

    Fulltext@MSK | Save
  • Direct evidence for new T cell production in patients after either T cell-depleted or unmodified allogeneic hematopoietic stem cell transplants
    Meeting Abstract

    Lewin, S. R.; Heller, G.; Zhang, L.; Rodrigues, E.; Skulsky, E.; Small, T. N.; van den Brink, M.; Kernan, N. A.; O'Reilly, R. J.; Ho, D. D.; more...
    Blood (2000)

    Fulltext@MSK | Save
  • Interleukin-7 administration after allogeneic bone marrow transplantation enhances immune reconstitution without aggravating GVHD
    Meeting Abstract

    Alpdogan, O.; Schmaltz, C.; Muriglan, S. J.; Kappel, B. J.; Rotolo, J.; van den Brink, M. R. M.
    Blood (2000)

    Fulltext@MSK | Save
  • Fas-deficient B6.lpr and Fas ligand-defective B6.gld mice are more susceptible to graft-versus-host disease
    Meeting Abstract

    van den Brink, M. R. M.; Moore, E.; Horndasch, K. J.; Crawford, J. M.; Hoffman, J.; Murphy, G. F.; Burakoff, S. J.
    Blood (1999)

    Fulltext@MSK | Save
  • Differential use of Fas ligand and perforin effector pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia
    Meeting Abstract

    van den Brink, M. R. M.; Horndasch, K. J.; Teshima, T.; Ferrara, J. L. M.; Burakoff, S. J.
    Blood (1999)

    Fulltext@MSK | Save
  • Requirement for SHC in T cell antigen receptor-mediated activation of a T cell hybridoma
    Meeting Abstract

    van den Brink, M. R. M.; Pratt, J. C.; Igras, V. E.; Walk, S. F.; Ravichandran, K. S.; Burakoff, S. J.
    Blood (1999)

    Fulltext@MSK | Save